Skip to main content
WeightCited

Alpha-Lipoic Acid per Obesity

B Evidenze Almeno un trial randomizzato lo supporta, con risultati per lo più coerenti.

Meta-analysis of 12 RCTs (n=534) found significant weight loss of 1.27 kg and BMI reduction of 0.43. A 20-week RCT (n=360) found 1,800 mg/day reduced body weight by 2.1%. Higher doses and longer durations showed greater effects.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dalpha\u002Dlipoic\u002Dacid\u0026condition\u003Dobesity'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

Meta-analysis of 12 RCTs (n=534) found significant weight loss of 1.27 kg and BMI reduction of 0.43. A 20-week RCT (n=360) found 1,800 mg/day reduced body weight by 2.1%. Higher doses and longer durations showed greater effects.

Key Study Findings

Other
Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical …
Dose: None vs: None Outcome: Cognitive function Effetto: None None

Popolazione: Rat model

In Vitro
α-Lipoic acid attenuates obesity-associated hippocampal neuroinflammation and increases the levels of brain-derived neurotrophic factor in …
Dose: None vs: Ovariectomized rats on high-fat diet without alpha-LA Outcome: Hippocampal neuroinflammation and BDNF levels Effetto: None None

Popolazione: Ovariectomized rats fed high-fat diet

Key Statistics

12

Studi

534

Partecipanti

Positive

B

Grado

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
300-600 mg/day
ralaactiveform:
150-300 mg/day
weightmanagement:
600-1,800 mg/day

Limite massimo: 1,800 mg/day; GI side effects at higher doses

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
None -- Positive --

Momento migliore per l'assunzione: 30 minutes before meals on empty stomach (food reduces absorption by ~30%)

Safety & Side Effects

Effetti collaterali segnalati

  • Nausea
  • Skin rash
  • Hypoglycemia (when combined with diabetes medications)
  • GI discomfort

Interazioni note

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • Thyroid medications (may affect thyroid hormone levels)
  • Chemotherapy agents (antioxidant interaction)

Livello di assunzione massimo tollerabile: 1,800 mg/day; GI side effects at higher doses

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Alpha-Lipoic Acid help with Obesity?
Based on 12 studies with 534 participants, there is moderate evidence from clinical studies that Alpha-Lipoic Acid may support Obesity management. Our evidence grade is B (Good Evidence).
How much Alpha-Lipoic Acid should I take for Obesity?
Studies have used various dosages. A commonly studied range is 300-600 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Alpha-Lipoic Acid?
Reported side effects may include Nausea, Skin rash, Hypoglycemia (when combined with diabetes medications), GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Alpha-Lipoic Acid and Obesity?
We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 534 total participants. The overall direction of effect is positive.

References

  1. [1] Eman N Hosny et al.. Physiol Behav. 2024. Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical changes in high-fat diet-induced obese … doi:10.1016/j.physbeh.2024.114697 PubMed
  2. [2] Yulian Miao et al.. Int J Mol Med. 2013. α-Lipoic acid attenuates obesity-associated hippocampal neuroinflammation and increases the levels of brain-derived neurotrophic factor in ovariectomized rats fed a high-fat … doi:10.3892/ijmm.2013.1482 PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.